What's breaking now, across thousands of outlets.
Judi Health is launching a new Part D plan that aims to lean on its tech stack to drive transparency and outcomes.
We haven't written up this one. Fierce Healthcare has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Rapport Therapeutics said Tuesday its investigational oral drug that dials down the effect of AMPA receptors has cleared a mid-stage trial in bipolar mania, paving the way for registrational studies…
Unlocking the Arctic’s subterranean DNA must ensure a delicate balance between scientific rigor and ethical stewardship. Synthetic biology and chemistry could help discovery of new life-saving…
The oysters were recalled after a number of reported illnesses and hospitalizations.
Patients across the U.S. will soon have access to a new cervical cancer test collected from the comfort of their own home—no stirrups, speculum, or in-person doctor’s visit needed.
Neurokinin receptor (NKR) antagonists are already widely used to treat menopausal hot flashes, providing an effective nonhormone treatment.
The aging brain may be undergoing a remarkable transformation rather than simply losing its abilities, shifting its focus from remembering details to understanding the bigger picture.
